Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

Clinical trial NCT07717788 · COMPLETED

Trial details

NCT number: NCT07717788
Sponsor: Alkufa university\\collage of pharmacy
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal Statin Therapy

Start date: 2025-02-01
Primary completion: 2026-07-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.